ArticleTranslational lung cancer research2025

Combination of racotumomab immunotherapy with programmed death-1 blockade in a preclinical model of non-small cell lung cancer.

Valeria I Segatori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.